Kawakami Junichi

カワカミジュンイチ | Kawakami Junichi

Affiliation and department：
Job title：教授
Research theme for competitive and other funds (15)：

2021 - 2024 Investigation of interindividual factors determining the clinical effects of peripherally-acting mu-opioid receptor antagonist under cancer conditions
2020 - 2023 PK-PD解析に基づく自己免疫疾患に対する低分子分子標的薬の投与設計法の確立
2020 - 2023 Kinetic analyses of thyroid hormone based on hepatic uptake transporter activity during the perinatal period
2018 - 2021 Investigation of interindividual variability in pharmacokinetics of and clinical responses to neuropathic pain medications in cancer patients
2017 - 2020 Prediction of opioid analgesics pharmacokinetics using the biomarkers of drug metabolizing enzyme activity in cancer patients

Show all

Papers (48)：

Kenta Sakaguchi, Takafumi Naito, Kohei Hoshikawa, Yukari Miyadera, Hironari Tanaka, Emi Nakatsugawa, Takahisa Furuta, Ken Sugimoto, Junichi Kawakami. Characterization of plasma vonoprazan and CYP3A activity using its endogenous marker and genetic variants in patients with digestive system disorders. Drug Metabolism and Pharmacokinetics. 2024. 101027-101027
Koji Suzuki, Tatsuya Yagi, Junichi Kawakami. Long-term efficacies of selective vasodilators in pulmonary arterial hypertension: a comprehensive comparison using a spontaneous reporting database. Naunyn-Schmiedeberg's Archives of Pharmacology. 2024. 397. 7. 4981-4992
Emi Nakatsugawa, Takafumi Naito, Yumi Imoto, Kaito Shibata, Takaaki Ono, Junichi Kawakami. Characterization of endogenous markers of hepatic function in patients receiving itraconazole treatment for prophylaxis of deep mycosis. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2023. 29. 3. 244-249
Yukari Miyadera, Takahiro Yamada, Yumi Imoto, Tatsuya Yagi, Takafumi Naito, Junichi Kawakami. Characterization of plasma daptomycin in patients with serum highly glycated albumin and obesity. Journal of Infection and Chemotherapy. 2023. 29. 2. 119-125
望月啓志, 柴田海斗, 内藤隆文, 下山久美子, 小川法良, 川上純一. 関節リウマチ患者における血清中トシリズマブ濃度及びIL-6濃度に基づくCYP3A活性の変動性評価. 日本臨床薬理学会学術総会抄録集. 2022. 43回. 3-2

ｍore...

MISC (83)：

柴田海斗, 柴田海斗, 望月啓志, 小川法良, 川上純一, 内藤隆文. Relationships between serum tocilizumab and serum FcRn-binding proteins or soluble IL-6 receptor in rheumatoid arthritis patients. 臨床薬理の進歩. 2024. 45
中津川瑛美, 内藤隆文, 柴田海斗, 前川真人, 川上純一. Impacts of CYP3A5 and ABCB1 genetic polymorphisms and cachexia progression on plasma naldemedine in cancer patients. 日本薬学会年会要旨集(Web). 2023. 143rd
室伏琢磨, 室伏琢磨, 八木達也, 辻大樹, 古島大資, 古島大資, 伊藤邦彦, 川上純一. Long-term changes in renal function in patients with proton pump inhibitors: A Japanese single center register-based longitudinal study. 日本薬学会年会要旨集(Web). 2023. 143rd
八木達也, 見野靖晃, 三浦基靖, 加藤弘美, 加藤弘美, 内藤隆文, 土井松幸, 土井松幸, 御室総一郎, 御室総一郎, et al. 術後患者におけるデクスメデトミジンの睡眠の質改善効果の個体間変動要因の検証. 日本臨床薬理学会学術総会抄録集(Web). 2023. 44th
八木達也, 川上純一. 【薬剤疫学の医療への貢献】臨床における薬剤疫学の実際. Precision Medicine. 2022. 5. 14. 1279-1282

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page